Junshi Biosciences strengthens board, abolishes supervisors

Dr. Yang Jin has been elected as an independent non-executive director of Junshi Biosciences, effective September 29, 2025, with an annual director's fee of RMB200,000. Her election, along with other amendments, was approved at the extraordinary general meeting (EGM) held on the same date. Following these changes, Dr. Yang Jin will join the remuneration and appraisal committee, while Ms. Lu Kun has been elected to the nomination committee. Both will serve until the end of the fourth session of the board.

Dr. Li Xin, aged 46, has been appointed as an employee representative director of the fourth session of the board, also effective September 29, 2025. Dr. Li, who joined the group in October 2023, currently serves as an executive director and senior vice president of government affairs.

Furthermore, the board of supervisors has been abolished following shareholder approval of amendments to the articles of association at the EGM on September 29, 2025. This change streamlines the company's governance structure, reflecting a strategic shift in its oversight mechanisms.